AIM: Plasma leptin concentrations not only correlate with body fat mass, but also with the degree of hypertensive retinopathy. The present study was designed to further examine, whether leptin's proliferative, proangiogenic activity relates to a yet uncovered anti-apoptotic effect. RESULTS: Leptin (10 -50 nmol=l) concentration-dependently reduced apoptosis in HUVECs (human umbilical vein endothelial cells), HAVECs (human adult vein endothelial cells) and HMECs (human microvascular endothelial cells) by 20% (P 0.05). These findings were supported by increased expression of the apoptosis inhibitor bcl-2 ( þ 55%, P 0.05) as well as by differential modulation of the respective cell cycle checkpoint genes=proteins p53 ( 7 20%, P 0.01), p21
Introduction
Obesity is associated with increased risk of arterial hypertension and facilitates vascular complications such as retinopathy and nephropathy. 1 Plasma concentrations of the ob gene transcript, leptin, are markedly increased in obese subjects and relate to body fat mass. 2 Moreover, plasma leptin correlates with the degree of hypertensive retinopathy. 3 Since functional leptin receptors are expressed by endothelial cells, 4 ,5 the vasculature is a potential target for leptin action. Leptin was shown to promote oxidative stress 6, 7 and proliferation of vascular endothelial cells 5 and to induce neovascularization in rat corneas. 4 The present study was designed to better understand the underlying mechanisms of leptin's proangiogenic effects and to uncover a hitherto unknown anti-apoptotic action in endothelial cells from different vascular beds.
Methods

Cell cultures
Pools (10 donors, passage 2 -5) of human uterus and skin microvascular endothelial cells (HMECs, Technoclone, Austria; cultured according to the manufacturer's instructions) and individual isolates of human umbilical (HUVECs, first subculture) and adult (HAVECs, harvested for bypass procedures; 2nd to 5th subculture) vein endothelial cells, isolated and cultured as described previously, 8 -10 were exposed to 10 -100 nmol=l human recombinant leptin (Alexis, Switzerland) in Optimem 1 (Gibco, Scotland) supplemented with 5% fetal bovine serum and antibiotics and tested for apoptosis (48 h), proliferation (48 h) and associated gene=protein expression (24 h).
Proliferation
Proliferation of endothelial cells (with=without leptin) was determined in quadruplicates by 3 H-thymidine incorporation as described previously. 8 Results are expressed as percentage of intra-individual control cultures (without leptin) set as 100%.
Apoptosis 8,9
Exponentially growing endothelial cells were labeled with 3 H-thymidine (1 mCi=ml) until reaching confluency (72 h). After seeding into 24-well plates and exposure to leptin, cells were lysed and radioactivity of fragmented (apoptotic) DNA (separated by centrifugation) was expressed as a percentage of total DNA in relation to intra-individual control cultures (without leptin, set as 100%).
Northern blots 8, 9 Total cellular RNA extracted from endothelial cells (with=without leptin) was electrophoresed on 1% formaldehyde agarose gels and immobilized on nylon membranes (Amersham, UK). Hybridization with 32 P-labeled cDNA (p21 WAF-1=Cip1 , 8 p53; ATCC, USA) and 28S-rRNA probes (Clontech, USA, for correction of loading inequalities) was carried out as described previously.
8,9
Western blots 8 Endothelial cells (with=without leptin) were lysed with cold Weinberg buffer containing protease inhibitors 8 and a freeze -thaw cycle. After centrifugation, aliquots of the supernatant (10 mg protein) were electrophoresed (SDS -PAGE) and transferred onto nitrocellulose membranes (Schleicher & Schüll, Germany). Blocking of unspecific binding sites, incubation with primary (p53, Santa Cruz, USA; p21 WAF-1=Cip1 , Transduction, USA; pRb and bcl-2, both Calbiochem, USA) and secondary antibodies (sheepanti-mouse Ig, Amersham, UK) as well as densitometric evaluation were performed as described previously. 8 
Statistics
Data are means AE s.e. Statistics were performed using pairedsamples t-test with Bonferroni correction for multiple comparisons.
Results
Leptin (10 nmol=l) increased proliferation in HUVECs and HMECs to 136 AE 10% (n ¼ 9, P 0.01) and 143 AE 10% (n ¼ 3 pools, P 0.05) of control (set to 100%), respectively. These effects are comparable to those of 1 nmol=l VEGF (142 AE 6% of control, n ¼ 8, P 0.001) obtained in the same experimental setting. Leptin concentration-dependently inhibited apoptosis in HUVECs, HMECs and HAVECs, the latter being the most responsive cell type ( Figure 1A ). Higher concentrations of leptin did not further augment that effect (data not shown). Leptin increased protein expression of the apoptosis inhibitor bcl-2 ( þ 55%, Figures 1B and 2A) and of the hyperphosphorylated form of the Retinoblastoma protein (pRb, þ 123%, Table  1 , Figure 2A ), but decreased that of p53 (tumor suppressor) to 80% and that of p21 WAF-1=Cip1 (inhibitor of cyclin dependent Leptin inhibits endothelial apoptosis M Artwohl et al kinases) to 77% of control (set as 100%, Table 1 , Figure 2B ), reflecting the respective mRNA expression (p53: 87 AE 5; p21 WAF-1=Cip1 : 85AE 4; n ¼ 4, P 0.05; Figure 2B ).
Discussion
The present study provides evidence for a potent proliferative activity of leptin in micro-and macrovascular endothelial cells from adult humans which is in agreement with recent findings in HUVECs and porcine aortic endothelial cells. 4, 5 This effect most likely relates to reduction of the cell cycle checkpoint genes=proteins p53 and p21 ( Figure 2B ) allowing hyperphosphorylation of pRb (Table 1, Figure 2A ). Liberation of the transcription factor E2F by hyperphosphorylated pRb initiating transcription of Sphase genes then promotes cell cycle progression in response to leptin. Whether pRb itself or E2F mediated activation of Sphase genes, apart from their role in cell cycle control, represent survival factors rescuing endothelial cells from apoptosis, still remains a matter of debate. 8, 11 At present, there is only limited knowledge on leptin's pro-=anti-apoptotic effects in vascular cells. While leptin was found to trigger apoptosis in adipose tissue vasculature of leptin deficient C57B1-ob=ob mice, 12 others abrogated leptin to affect apoptosis in quiescent HUVECs. 5 The present study now clearly shows that leptin inhibits apoptosis in proliferating human fetal (HUVECs) as well as in human adult micro-and macrovascular endothelial cells. Controversial findings probably reflect different experimental settings, including species and vascular bed 12 as well as cell cycle phase. 5 Cell cycle dependent responses were previously shown for pro-apoptotic agents (TNF-a 11 ), and may well apply to anti-apoptotic substances. The anti-apoptotic activity of leptin in proliferating human micro-and macrovascular endothelial cells is in line with the observed upregulation of bcl-2, a prominent inhibitor of apoptosis. 13, 14 Leptin thus not only mimics VEGF action by triggering neoangiogenesis and proliferation of endothelial cells, but also by inhibiting endothelial apoptosis 15 in a bcl-2 dependent manner. 13 The leptin concentration of 10 nmol=l employed in this study exceeds the peripheral plasma concentrations of $ 5 nmol=l reported in lean and obese humans. 16 In severe obesity, however, vascular endothelium is likely to be exposed to much higher concentrations resulting from local leptin release. 17, 18 Of note, leptin correlates with the severity of hypertensive retinopathy 3 and stimulates proliferation of renal glomerular cells leading to kidney damage, glomerulosclerosis and proteinuria. 19 Thus, the endothelial effects of leptin might also play a role in the pathogenesis of hypertension-associated complications in obese patients.
In conclusion, the present findings indicate that increased bcl-2 dependent survival of endothelial cells may add to leptin's proangiogenic activity and promote the development of vascular proliferative disease in obesity. (mRNA and protein) in HUVECs. The 28S-rRNA control probe (B) was used to correct for loading inequalities.
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